Molecular Oncology of Gall Bladder Cancer
- PMID: 33994729
- PMCID: PMC8119519
- DOI: 10.1007/s13193-019-01008-2
Molecular Oncology of Gall Bladder Cancer
Abstract
Gall bladder carcinoma (GBC) is a worldwide problem, with a higher incidence in areas of the world where cholelithiasis is common. As GBC is usually diagnosed in an advanced stage, the mortality is high. An understanding of the molecular pathways of carcinogenesis and the mutations involved in the development and progression of GBC could be useful in early diagnosis. Understanding molecular markers of prognosis as well as predictors of outcome could also potentially benefit patients undergoing treatment. New therapies targeting major molecular pathways and immunotherapy are exciting novel therapeutic options. This review focuses on the current understanding of the molecular oncology of GBC.
Keywords: Biliary cancers; Gall bladder carcinoma; Immunotherapy; Molecular oncology; Mutations; Targeted therapy.
© Indian Association of Surgical Oncology 2019.
Conflict of interest statement
Conflict of InterestThe authors declare that they have no conflict of interest.
Figures
Similar articles
-
Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer.World J Gastrointest Oncol. 2023 Dec 15;15(12):2053-2063. doi: 10.4251/wjgo.v15.i12.2053. World J Gastrointest Oncol. 2023. PMID: 38173427 Free PMC article. Review.
-
[Biliary calculosis, cholesterosis of the gallbladder, xanthogranulematous cholecystitis: clinical-morphological parallels].Ter Arkh. 2008;80(2):66-71. Ter Arkh. 2008. PMID: 18372600 Russian.
-
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma.J Carcinog. 2021 Jun 9;20:7. doi: 10.4103/jcar.JCar_4_21. eCollection 2021. J Carcinog. 2021. PMID: 34321957 Free PMC article.
-
Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.World J Clin Cases. 2015 Mar 16;3(3):231-44. doi: 10.12998/wjcc.v3.i3.231. World J Clin Cases. 2015. PMID: 25789296 Free PMC article. Review.
-
Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population.Clin Microbiol Infect. 2007 May;13(5):525-31. doi: 10.1111/j.1469-0691.2007.01690.x. Epub 2007 Mar 7. Clin Microbiol Infect. 2007. PMID: 17346303
Cited by
-
Expression of inflammatory proteins STAT & NFĸB for phenotypic diagnosis of gall bladder cancer: A pilot study.Indian J Med Res. 2025 Apr;161(4):414-419. doi: 10.25259/IJMR_1461_2024. Indian J Med Res. 2025. PMID: 40536380 Free PMC article.
-
Impact of ABCB1 and ABCG2 Transporter in Outcome of Gallbladder Cancer.J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101410. doi: 10.1016/j.jceh.2024.101410. Epub 2024 Apr 12. J Clin Exp Hepatol. 2024. PMID: 38716375 Free PMC article.
References
-
- Are C, Ahmad H, Ravipati A, Croo D, Clarey D, Smith L, Price RR, Butte JM, Gupta S, Chaturvedi A, Chowdhury S. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2017;115(5):580–590. - PubMed
-
- Randi G, Franceschi S, la Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591–1602. - PubMed
-
- Park YK, Kim SW, Park YH. A clinical study of gallbladder carcinoma. Korean J Gastroenterol. 1989;21:113–122.
-
- Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, Ebara M, Matsutani S, Okuda K. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology. 1985;89:1258–1265. - PubMed
-
- Wistuba Ignacio I, GazdarAdi F. Gallbladder cancer: lessons from a rare tumor. Nat Rev Cancer. 2004;4:695–706. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials